Cargando…
Drug–drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants
Autores principales: | Mathy, François-Xavier, Dohin, Elisabeth, Bonfitto, François, Pelgrims, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514818/ https://www.ncbi.nlm.nih.gov/pubmed/30500876 http://dx.doi.org/10.1093/eurheartj/ehy780 |
Ejemplares similares
-
Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination
por: von Oertzen, Tim J, et al.
Publicado: (2019) -
Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help
por: Gargiulo, Giuseppe, et al.
Publicado: (2020) -
Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease
por: Jayaraj, Rama, et al.
Publicado: (2020) -
Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
por: Westphal, Sophia, et al.
Publicado: (2021) -
Increased absorption of phytosterols is the simplest and most plausible explanation for coronary artery disease risk not accounted for by non-HDL cholesterol in high cholesterol absorbers
por: Helgadottir, Anna, et al.
Publicado: (2020)